$0.89
+0.05 (+5.90%)
Open$0.87
Previous Close$0.84
Day High$0.89
Day Low$0.86
52W High$605.00
52W Low$225.30
Volume—
Avg Volume75.8K
Market Cap138.29M
P/E Ratio—
EPS$-1.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,385.7% upside
Current
$0.89
$0.89
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 808.54M | 786.29M | 56.95M |
| Net Income | -229,498,416 | -200,864,119 | 10.61M |
| Profit Margin | -28.4% | -27.0% | 18.6% |
| EBITDA | -162,931,453 | -150,525,022 | 17.54M |
| Free Cash Flow | — | — | 14.62M |
| Rev Growth | +2.8% | +2.8% | -4.9% |
| Debt/Equity | 0.51 | 0.51 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |